1 / 6

Global Cancer Biomarkers Market

Cancer is recognized as a major cause of mortality world over; accounting for 7.4 million (or 13%) of all deaths in 2004. The WHO estimates the incidence of cancer to continue rising to reach an estimated 9.2 million deaths in 2015. The rising prevalence of the disease forms one of the major factors driving the growth of the oncology biomarkers market.

sagmnm
Télécharger la présentation

Global Cancer Biomarkers Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MarketsandMarkets Presents Global Cancer Biomarkers Market (2010 - 2015) http://www.marketsandmarkets.com/Market-Reports/oncology-biomarkers-202.html

  2. According to a new market research report, ‘global oncology biomarker market’, published by MarketsandMarkets The global oncology biomarker market is expected to grow from $4.1 billion in 2009 to $9.5 billion in 2014 at a CAGR of 18.1% from 2009 to 2014. The Global Oncology Biomarkers Market report analyzes the oncology biomarkers diagnostics and discovery market over the period 2009-2014. The report studies the major market drivers, restraints, and opportunities for the oncology biomarkers market. Browse>> 45+data tables In-depth TOC “Global Oncology Biomarkers Market.” Early buyers will receive 10% customization of reports http://www.marketsandmarkets.com/Market-Reports/oncology-biomarkers-202.html

  3. The global oncology biomarker market is expected to grow from $4.1 billion in 2009 to $9.5 billion in 2014 at a CAGR of 18.1% from 2009 to 2014. The key factors driving the growth of the overall oncology biomarkers market include the rising prevalence of cancer across the globe; and the early diagnosis and enhanced testing capabilities biomarkers facilitate. Further, U.S. government initiatives and increasing patient awareness are also enhancing market growth. Market players are now focusing on new product and consolidations to enhance their commercial portfolios. The most common strategies adopted by market players include agreement and collaborations to stabilize management costs and to take advantage of the core competencies of the partner company. http://www.marketsandmarkets.com/Market-Reports/oncology-biomarkers-202.html

  4. SCOPE AND FORMAT The report analyzes the Oncology biomarkers market into the following segments: 1.Oncology biomarkers discovery market 2.Oncology biomarkers diagnostics market The market data consists of aggregate sales figures of all oncology biomarkers submarkets. It analyzes the market aspects of products and services; sourcing key market developments from the top companies that it profiles. http://www.marketsandmarkets.com/Market-Reports/oncology-biomarkers-202.html

  5. Contact Us Mr. RohanNorth - Dominion Plaza, 17304 Preston Road, Suite 800, Dallas, TX 75252Tel: +1-888-6006-441Email: sales@marketsandmarkets.comMarketsandMarkets Bloghttp://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets http://www.marketsandmarkets.com/Market-Reports/oncology-biomarkers-202.html

  6. About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. http://www.marketsandmarkets.com/Market-Reports/oncology-biomarkers-202.html

More Related